The anticancer drug cisplatin interacts with the human erythrocyte membrane

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 55, Issue 5-6, 2000, Pages 461-466

  Suwalsky, Mario ^a   Hernández, Pedro ^a   Villena, Fernando ^c   Sotomayor, Carlos P ^b  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^c NONE

Author keywords

Anticancer Drug; Cisplatin; Erythrocyte Membrane

Indexed keywords

CELL MEMBRANE; CISPLATIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLETHANOLAMINE; ERYTHROCYTE; FLUORESCENCE SPECTROSCOPY; LIPID BILAYER; MONOLAYER; PHOSPHATIDYLSERINE; REACTION MECHANISM; X RAY DIFFRACTION ANALYSIS;

EID: 0343526391     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2000-5-624     Document Type: Article

References (24)

1. Atkinson D., Hauser H., Shipley G. G. and Stubbs J. M. (1974), Structure and morphology of phosphatidylserine dispersions. Biochim. Biophys. Acta 339, 10-29.
2. Burger K. N. J., Staffhorst R. W. H. M. and de Kruijf B. (1999), Interaction of the anti-cancer drug cisplatin with phosphatidylserine in intact and semi-intact cells. Biochim. Biophys. Acta 1419, 43-54.
3. Devaux P. F. and Zachowsky A. (1994), Maintenance and consequences of membrane phospholipid asymmetry. Chem. Phys. Lipids 73, 107-120.
4. Grunicke H. and Hoffmann J. (1992), Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmacol. Ther. 55, 1-30.
5. Grunicke H., Doppler S. A., Finch S. A. E., Greinert R., Grünewald K., Hoffmann J., Maly K., Stier A., Scheidl F. and Thomas J. K. (1985), Effects of nitrogen mustard on potassium transport system and membrane structure of Ehrlich ascite tumor cells. Adv. Enzyme Regul. 23, 277-290.
6. Hammers F. P. T., van der Hoop R. G., Steerenburg P. A., Neijt J. P. and Gispen W. H. (1991), Putative neurotrophic factors in the protection of cisplatin-induced peripheral neuropathy in rats. Toxicol. Appl. Pharmacol. 111, 514-522.
7. Holmes J., Stanko J., Varchenko M., Ding H., Madden V. J., Bagnell C. R., Wyrick S. D. and Chancy S. G. (1998), Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicol. Sci. 46, 342-351.
8. Huang H., Zhu L., Reid B. R., Drobny G. P. and Hopkins P. B. (1995), Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270, 1842-1845.
9. Lange Y., Gough A. and Steck T. L. (1982), Role of the bilayer in the shape of the isolated erythrocyte membrane. J. Membr. Biol. 69, 113-123.
10. Luxo C., Jurado A. S., Custodio J. B. A. and Madeira V. M. (1996), Use of Bacillus stearothermphilus as a model to study tamoxifen-membrane interactions, Toxicol. in vitro 10, 463-471.
11. Marutaka M., Iwagachi H., Suguri T., Tanaka N. and Orita K. (1994) Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin. Res. Commun. Mol. Pathol. Pharmacol. 85, 163-170.
12. Mollman J. (1990), Cisplatin neurotoxicity. New Engl. J. Med. 322, 126-127.
13. Moolenaar W. H.(1988), Ionic signals in the action of growth factors. Ann. N. Y. Acad. Sci. 551, 179-185.
14. Parasassi T. and Gratton E. (1995), Membrane lipid domains and dynamics as detected by laurdan fluorescence 5, 59-69.
15. Roelofsen R. (1991), Molecular architecture and dynamics of the plasma membrane lipid bilayer: the red blood cell as a model. Infection (Suppl. 4) 19, S206-S209.
16. Scanlon K. J., Kashani-Sabet M., Miyachi H., Sowers L. C. and Rossi J. (1989), Molecular basis of cisplatin resistance in human carcinomas: model systems and patients. Anticancer Res. 9, 1301-1312.
17. Sheetz M. P. and Singer S. J. (1974), Biological membranes as bilayer couples. A molecular mechanism of drug induced interactions. Proc. Natl. Acad. Sci. USA 71, 4457-4461.
18. Speelmans G., Staffhorst R. W. H. M., Versluis K., Reedijk J. and de Kruijff, B. (1997), Cisplatin complexes with phosphatidylserine in membranes. Biochemistry 36, 10545-10550.
19. Speelmans G., Sips W. H. H. M., Grisel R. J. H., Staffhorst R. W. H. M., Fichtinger-Schepman A. M. J., Reedijk J. and de Kruijff B. (1996), The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration. Biochim. Biophys. Acta 1283, 60-66
20. Suwalsky M., Hernández P., Villena F., Aguilar F. and Sotomayor C. P. (1999), The anticancer drug adriamycin interacts with the human erythrocyte membrane. Z. Naturforsch. 54c, 271-277.
21. Suwalsky M., Hernández P., Villena F and Sotomayor C. P. (1999), The anticancer drug chlorambucil interacts with the human erythrocyte membrane and model phospholipid bilayers. Z. Naturforsch. 54c (in press).
22. Suwalsky M., Hernández P., Villena F., Aguilar F. and Sotomayor C. P. (1998), Interaction of the anticancer drug tamoxifen with the human erythrocyte membrane and molecular models. Z. Naturforsch. 53c, 182-190.
23. Suzuki M. and Kaga K. (1997), Effect of cisplatin on the basement membrane anionic sites in the ampulla, macula, and stria vascularis of guinea pigs. Ann. Otol. Rhynol. Laryngol. 106, 971-975.
24. Yang D. van Boom S. S. Reedijk J. van Boom J. H. and Wang A. H. (1995), Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis. Biochemistry 34, 12912-12920.